What's new

Cyramza-H-C-2829-P46-0010 : EPAR - Assessment report

Mar 26, 2025 0

Cyramza-H-C-2829-P46-0010 : EPAR - Assessment report

Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Mar 26, 2025 0

Human medicines European public assessment report (EPAR): Alofisel, darvadstroce...

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025 0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, ...

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025 0

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab,...

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025 0

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab,...

Clinical Trials Information System (CTIS): Walk-in clinic - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 May 2025, 16:00 (CEST) to 14 May 2025, 17:00 (CEST)

Clinical Trials Information System (CTIS): Walk-in clin...

Mar 26, 2025 0

Clinical Trials Information System (CTIS): Walk-in clinic - May 2025, Online, Eu...

MedDRA important medical event terms list - version 28.0

Mar 26, 2025 0

MedDRA important medical event terms list - version 28.0

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025 0

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Da...

Decision on rules concerning the handling of declared i...

Mar 26, 2025 0

Decision on rules concerning the handling of declared interests of national expe...

Decision of the European Medicines Agency on rules rela...

Mar 26, 2025 0

Decision of the European Medicines Agency on rules relating to Articles 11, 11a ...

MedDRA important medical event terms list - version 28.1

Mar 26, 2025 0

MedDRA important medical event terms list - version 28.1

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine...

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, ...

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory s...

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mR...

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Emadine, emedastine, D...

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, ...

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, D...

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Prasugrel Viatris (pre...

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetiu...

Human medicines European public assessment report (EPAR): Sugammadex Fresenius Kabi, sugammadex, Date of authorisation: 15/07/2022, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025 0

Human medicines European public assessment report (EPAR): Sugammadex Fresenius K...

Annual list of grants 2024

Mar 25, 2025 0

Annual list of grants 2024

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 May 2025, 14:00 (CEST) to 8 May 2025, 16:00 (CEST)

Second EMA / Alliance for Regenerative Medicine bilater...

Mar 25, 2025 0

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, Europ...

CTIS newsflash - 25 March 2025

Mar 25, 2025 0

CTIS newsflash - 25 March 2025

17
18
19
20
21

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.